Stryker released its Q1 financials after markets closed on 30 April. The company’s shares on the Nasdaq stock exchange opened 0.6% down at $313.34 on 31 April compared to the pr ...

Swiss biotech AC Immune discusses its PET tracer's potential in realising precision medicine approaches to neurodegenerative diseases.

Dexcom is maintaining its prior FY26 outlook in view of the current geopolitical realities such as higher oil prices due to Iran’s closure of the Strait of Hormuz in response to the US-Israel’s war ...

The FDA has awarded a breakthrough device designation for Capitan Orthopedics' SupraSpacer implant for patients with irreparable rotator cuff tears.

MintNeuro has signed a partnership with Motif Neurotech to advance the development of miniature BCI therapy for mental health conditions.

GE HealthCare has cut its 2026 growth outlook by 3.3% at the top end, citing increasing freight costs for oil and other materials.

The MUSC and Revival Healthcare Capital have entered a partnership aimed at advancing the clinical development of medical technologies.

Neuromodulation is an adjunct to medication for Parkinson’s symptom management, with growing interest in whether it could one day contribute to disease-modifying therapies.